Tokyo, Aug. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060444) titled 'A study investigating whether sleep apnea treatment affects swallowing function' on July 31.
Study Type:
Observational
Primary Sponsor:
Institute - Yamato Hidakami Medical Corporation
Condition:
Condition - Obstructive sleep apnea (OSA)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To determine whether OSA treatment influences swallowing-related symptoms.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
=
Gender - Male and Female
Key inclusion criteria - Untreated patients, including those prior to initiating OSA therapy
Patients who met the Japanese health insurance criteria for CPAP coverage and were receiving either CPAP therapy or CPAP with OA therapy.
Key exclusion criteria - Poor CPAP adherence
Prior diagnosis of dysphagia
Severe asthma or Chronic obstructive pulmonary disease (COPD)
Neurodegenerative diseases or neuromuscular disorders
History of stroke
History of head and neck surgery
Target Size - 400
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2025 Year 06 Month 30 Day
Date of IRB - 2025 Year 08 Month 30 Day
Anticipated trial start date - 2025 Year 07 Month 01 Day
Last follow-up date - 2025 Year 07 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069129
Disclaimer: Curated by HT Syndication.
